Blueclinical, Ltd.   Report issue

For profit Phase 2
Founded: Matosinhos Portugal (2012)

Organization Overview

First Clinical Trial
2016
NCT02777489
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Blueclinical, Ltd.